Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2017 / Article

Retraction | Open Access

Volume 2017 |Article ID 2575273 | https://doi.org/10.1155/2017/2575273

Evidence-Based Complementary and Alternative Medicine, "Retracted: Silymarin Accelerates Liver Regeneration after Partial Hepatectomy", Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 2575273, 1 page, 2017. https://doi.org/10.1155/2017/2575273

Retracted: Silymarin Accelerates Liver Regeneration after Partial Hepatectomy

Received08 Aug 2017
Accepted08 Aug 2017
Published23 Nov 2017

Evidence-Based Complementary and Alternative Medicine has retracted the article titled “Silymarin Accelerates Liver Regeneration after Partial Hepatectomy” [1]. The article was found to contain images with the following concerns: There are irregularities in the background in Figures and ; the tubulin controls in Figures and are the same; Figure , Cyclin B (72 hrs) is the same as Figure , TGF beta1 (24 hrs); Figure , the lanes in the TGF-alpha rows at 6 hours and 72 hours do not align. The authors provided corrected figures, which are available as Supplementary Materials, but could not provide the underlying blots.

Supplementary Materials

Corrected Figures 1, 3, 5 and 6.

  1. Supplementary Material

References

  1. J.-P. Wu, C.-C. Tsai, Y.-L. Yeh et al., “Silymarin accelerates liver regeneration after partial hepatectomy,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 603529, 14 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2017 Evidence-Based Complementary and Alternative Medicine. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views829
Downloads228
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.